Squarepoint
EVH icon

Squarepoint’s Evolent Health EVH Stock Holding History

Squarepoint’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-121,100
Closed -$1.36M – 4817
2024
Q4 		$1.36M Buy
121,100
+40,500
+50% +$712K ﹤0.01% 2775
2024
Q3 		$2.28M Buy
+80,600
New +$2.08M ﹤0.01% 1974

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Squarepoint's EVH Position: Q2 2026 in Review

Squarepoint reduced its Evolent Health (EVH) stake by 36% in Q2 2026, selling an estimated $535K and leaving 250,842 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #2645.

Squarepoint first reported a position in EVH in Q4 2016 and has held it in 21 quarters since. The position peaked at $3.81M in Q4 2025. 199 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Squarepoint held 250,842 shares of Evolent Health worth $1.36M as of Q2 2026.
  • Squarepoint sold 139,452 Evolent Health shares in Q2 2026, an estimated $535K.
  • Evolent Health made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #2645 holding.
  • Squarepoint first reported a position in Evolent Health in Q4 2016 and has held it in 21 quarters since.
  • Squarepoint's Evolent Health position peaked at $3.81M in Q4 2025.
  • 199 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.